Effects of triamcinolone acetonide, sodium hyaluronate, amikacin sulfate, and mepivacaine hydrochloride, alone and in combination, on morphology and matrix composition of lipopolysaccharide-challenged and unchallenged equine articular cartilage explants

被引:34
作者
Bolt, David M. [1 ]
Ishihara, Akikazu [2 ]
Weisbrode, Stephen E. [2 ]
Bertone, Alicia L. [1 ]
机构
[1] Ohio State Univ, Comparat Orthopaed Res Labs, Dept Vet Clin Sci, Columbus, OH 43210 USA
[2] Ohio State Univ, Comparat Orthopaed Res Labs, Dept Vet Biosci, Columbus, OH 43210 USA
基金
中国国家自然科学基金;
关键词
D O I
10.2460/ajvr.69.7.861
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To evaluate the effects of triamcinolone acetonide (TA), sodium hyaluronate (HA), amikacin sulfate (AS), and mepivacaine hydrochloride (MC) on articular cartilage morphology and matrix composition in lipopolysaccharide (LPS)-challenged and unchallenged equine articular cartilage explants. Sample Population- 96 articular cartilage explants from 4 femoropatellar joints of 2 adult horses. Procedures-Articular cartilage explants were challenged with LIPS (100 ng/mL) or unchallenged for 48 hours, then treated with TA, HA, AS, and MC alone or in combination for 96 hours or left untreated. Cartilage extracts were analyzed for glycosaminoglycan (GAG) content by dimethyl-methylene blue assay (ng/mg of dry wt). Histomorphometric quantification of total lacunae, empty lacunae, and lacunae with pyknotic nuclei was recorded for superficial, middle, and deep cartilage zones. Results- LPS induced a significant increase in pyknotic nuclei and empty lacunae. Treatment with TA or HA significantly decreased empty lacunae (TA and HA), compared with groups without TA or HA, and significantly decreased empty lacunae of LIPS-challenged explants, compared with untreated explants. Treatment with AS or MC significantly increased empty lacunae in unchallenged explants, and these effects were attenuated by TA. Treatment with MC significantly increased empty lacunae and pyknotic nuclei and, in combination with LIPS, could not be attenuated by TA. Content of GAG did not differ between unchallenged and LPS-challenged explants or among treatments. Conclusions and Clinical Relevance-Treatment with TA or HA supported chondrocyte morphology in culture and protected chondrocytes from toxic effects exerted by LIPS, AS, and MC.
引用
收藏
页码:861 / 867
页数:7
相关论文
共 40 条
[1]   INVITRO EFFECTS OF HYALURONAN ON PROSTAGLANDIN-E2 INDUCTION BY INTERLEUKIN-1 IN RABBIT ARTICULAR CHONDROCYTES [J].
AKATSUKA, M ;
YAMAMOTO, Y ;
TOBETTO, K ;
YASUI, T ;
ANDO, T .
AGENTS AND ACTIONS, 1993, 38 (1-2) :122-125
[2]   Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism [J].
Beluche, LA ;
Bertone, AL ;
Anderson, DE ;
Rohde, C .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2001, 62 (12) :1916-1921
[3]  
CARON JP, 1993, AM J VET RES, V54, P1116
[4]  
CARON JP, 1991, AM J VET RES, V52, P1622
[5]   In vitro exposure to 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes [J].
Chu, Constance R. ;
Izzo, Nicholas J. ;
Papas, Nicole E. ;
Fu, Freddie H. .
ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2006, 22 (07) :693-699
[6]  
CHUNEKAMRAI S, 1989, AM J VET RES, V50, P1733
[7]   Evaluation of risk factors associated with development of postoperative ileus in horses [J].
Cohen, ND ;
Lester, GD ;
Sanchez, LC ;
Merritt, AM ;
Roussel, AJ .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2004, 225 (07) :1070-1078
[8]   Effects of dosage titration of methylprednisolone acetate and triamcinolone acetonide on interleukin-1-conditioned equine articular cartilage explants in vitro [J].
Dechant, JE ;
Baxter, GM ;
Frisbie, DD ;
Trotter, GW ;
McIlwraith, CW .
EQUINE VETERINARY JOURNAL, 2003, 35 (05) :444-450
[9]   Effects of sodium hyaluronate and methylprednisolone acetate on proteoglycan synthesis in equine articular cartilage explants [J].
Doyle, AJ ;
Stewart, AA ;
Constable, PD ;
Eurell, JAC ;
Freeman, DE ;
Griffon, DJ .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2005, 66 (01) :48-53
[10]  
Dyson SJ., 2003, DIAGNOSIS MANAGEMENT, P93